Cargando…
Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults
The increasing global impact of dengue underscores the need for a dengue virus (DENV) vaccine. We assessed B-cell and T-cell responses following vaccination with four formulations of a tetravalent dengue purified inactivated vaccine (DPIV) in dengue-primed and dengue-naive adults from two studies (N...
Autores principales: | Friberg, Heather, Gargulak, Morgan, Kong, Amanda, Lin, Leyi, Martinez, Luis J., Schmidt, Alexander C., Paris, Robert M., Jarman, Richard G., Diaz, Clemente, Thomas, Stephen J., Moris, Philippe, Currier, Jeffrey R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622737/ https://www.ncbi.nlm.nih.gov/pubmed/36316335 http://dx.doi.org/10.1038/s41541-022-00537-2 |
Ejemplares similares
-
Phase I Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico
por: Diaz, Clemente, et al.
Publicado: (2018) -
Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults in the United States
por: Schmidt, Alexander C., et al.
Publicado: (2017) -
Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1
por: Friberg, Heather, et al.
Publicado: (2020) -
Safety and Immunogenicity of an AS03(B)-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study
por: Lin, Leyi, et al.
Publicado: (2020) -
Assessing the Diversity and Stability of Cellular Immunity Generated in Response to the Candidate Live-Attenuated Dengue Virus Vaccine TAK-003
por: Waickman, Adam T., et al.
Publicado: (2019)